Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Amylyx Pharmaceuticals, Inc.”

9 pharma patents match "Amylyx Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 9
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 9 pharmaceutical patents matching "Amylyx Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

9 results for “Amylyx Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 12246027

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  2. US 12186330

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  3. US 12138272

    Methods and compositions for treating amyotrophic lateral sclerosis

    Amylyx Pharmaceuticals, Inc. · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  4. US 11583542

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Feb 21, 2023 · Expires Feb 16, 2043

    granted
  5. US 11559533

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  6. US 11071742

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted
  7. US 10857162

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Dec 8, 2020 · Expires Dec 3, 2040

    granted
  8. US 10251896

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted
  9. US 9872865

    Compositions for improving cell viability and methods of use thereof

    Amylyx Pharmaceuticals, Inc. · Granted Jan 23, 2018 · Expires Jan 18, 2038

    granted